Atrás
Rango del Día
$22.12
$22.81
Rango de 52 Semanas
$18.80
$27.64
Volumen
517,035
Promedio 50D / 200D
$21.87
/
$23.66
Cierre Anterior
$22.11
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 138.5 | 0.4 |
| P/B | 1.4 | 2.9 |
| ROE % | 1.0 | 3.8 |
| Net Margin % | 1.0 | 3.9 |
| Rev Growth 5Y % | 7.6 | 10.0 |
| D/E | 0.7 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$4.95
$4.87 – $5.06
|
940 M | 2 |
| FY2029 |
$4.60
$4.52 – $4.70
|
920 M | 2 |
| FY2028 |
$5.18
$5.10 – $5.29
|
960 M | 3 |
Puntos Clave
Revenue grew 7.62% annually over 5 years — modest growth
ROE of 0.96% is below average
Generating 136.66M in free cash flow
P/E of 138.53 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.99%
Cash machine — converts 1942.86% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
7.62%
Revenue (1Y)3.63%
Earnings (1Y)N/A
FCF Growth (3Y)-1.02%
Calidad
Return on Equity
0.96%
ROIC1.84%
Net Margin0.97%
Op. Margin3.87%
Seguridad
Debt / Equity
0.66
Current Ratio4.54
Interest Coverage1.61
Valoración
P/E Ratio
138.53
P/B Ratio1.41
EV/EBITDA45.20
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.63% | Revenue Growth (3Y) | 3.74% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -59.05% |
| Revenue Growth (5Y) | 7.62% | Earnings Growth (5Y) | -36.02% |
| Profitability | |||
| Revenue (TTM) | 726.41M | Net Income (TTM) | 7.03M |
| ROE | 0.96% | ROA | 0.56% |
| Gross Margin | 71.50% | Operating Margin | 3.87% |
| Net Margin | 0.97% | Free Cash Flow (TTM) | 136.66M |
| ROIC | 1.84% | FCF Growth (3Y) | -1.02% |
| Safety | |||
| Debt / Equity | 0.66 | Current Ratio | 4.54 |
| Interest Coverage | 1.61 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 138.53 | P/B Ratio | 1.41 |
| P/S Ratio | 1.34 | PEG Ratio | -1.53 |
| EV/EBITDA | 45.20 | Dividend Yield | 0.00% |
| Market Cap | 974.43M | Enterprise Value | 1.27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 726.41M | 700.97M | 674.98M | 666.82M | 541.53M |
| Net Income | 7.03M | -99.56M | 41.96M | 15.91M | 41.98M |
| EPS (Diluted) | 0.16 | -2.15 | 0.89 | 0.34 | 0.92 |
| Gross Profit | 519.37M | 530.54M | 490.31M | 467.53M | 401.28M |
| Operating Income | 28.10M | -73.37M | 87.68M | 60.02M | 89.92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.26B | 1.55B | 1.57B | 1.68B | 2.08B |
| Total Liabilities | 571.81M | 775.17M | 704.26M | 906.19M | 1.34B |
| Shareholders' Equity | 693.11M | 778.35M | 870.13M | 775.01M | 730.41M |
| Total Debt | 454.38M | 638.85M | 586.04M | 763.39M | 1.13B |
| Cash & Equivalents | 158.55M | 276.77M | 153.30M | 104.14M | 585.58M |
| Current Assets | 547.97M | 745.13M | 509.99M | 498.33M | 866.05M |
| Current Liabilities | 120.59M | 309.92M | 97.38M | 147.77M | 521.12M |